Displaying items by tag: diabetes

Do you have Type 2 Diabetes? Are you 18 years or older? Not currently taking Insulin ? Are you currently being treated with stable doses of daily or weekly GLP-1 receptor agonist, the treatment can be with or without any of the following anti-diabetic drugs with stable doses: Metformin, Sulfonylureasa , Meglitinides (glinides), DPP-4 inhibitors, Sodium-glucose co-transporter 2 inhibitors, Alpha-glucosidase-inhibitors, Thiazolidinediones The University of Alabama at Birmingham, Department of Nutrition Sciences, in collaboration with Novo Nordisk, is conducting a 52 week research study comparing the efficacy and safety of once weekly IcoSema and once weekly semaglutide, Qualified participants will receive study drug free of charge and may be compensated for time and travel. For more information, and to see if you might be eligible to join, please contact (205) 996-4015 or email at ccnrn@uab.edu.

Do you have Type 2 Diabetes? Are you 18 years or older? Not currently taking Insulin? Are you currently being treated with stable doses of daily or weekly GLP-1 receptor agonist? This 52 week research study is seeking qualified participants to help compare the efficacy and safety of once weekly IcoSema and once weekly semaglutide. Qualified participants will receive study drug free of charge and may be compensated for time and travel. The treatment can be with or without any of the following anti-diabetic drugs with stable doses: Metformin, Sulfonylureasa , Meglitinides (glinides), DPP-4 inhibitors, Sodium-glucose co-transporter 2 inhibitors, Alpha-glucosidase-inhibitors, and Thiazolidinediones. For more information, and to see if you might be eligible to join, please contact 205-996-4015 or email at ccnrn@uab.edu.

You may be eligible to participate in the UAB’s Cardiovascular Research Biobank (CARBON), a repository of biological samples that will be used for future research about heart disease, diabetes, genomics, and more. Participants must be over the age of 18. The study will require one brief visit to UAB and collection of blood samples. Participants will be compensated. Please contact Nehal Vekariya at carbonstudy@uabmc.edu or 205-934-7173 if you are interested.

Clinical trial investigates diet as a way to remodel the body by re-partitioning energy away from metabolically harmful lipid stores.
The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting a research study to evaluate the effectiveness of an investigational drug to treat people with Type 2 Diabetes and obesity. To qualify, you must have Type 2 Diabetes, older than 18 years old, moderately overweight, diet-controlled or taking oral diabetes medications. Qualified participants will receive the study drug free of charge and compensation for time and travel. For more information, and to see if you might be eligible to join, please contact (205) 996-4015 or email at ccnrn@uab.edu.

We are looking for adults with type 2 diabetes for an exciting research study to see whether intermittent fasting and/or using light therapy can improve your blood sugar, improve your overall health, and reset your body clock. Participants will either eat early in the day, graze throughout the day, and/or use a special light therapy box or glasses. You may be eligible if you have type 2 diabetes, are 30-80 years old, are not taking insulin, and usually wake up between 5:00 and 9:00 am. The main part of the study lasts 16 weeks and involves two overnight tests in our clinic (which can be done on weekends, if preferred). Participants will receive $2400 for completing the study. 

If you are interested, please follow the link http://bit.ly/clocksstudy  to apply for the CLOCKS study. Or for more information, please contact our research team for more information: Errin Jessie or Kimberly Armstead at CLOCKSSTUDY@uab.edu or 205-975-3944 or 205-934-6202.

You may qualify to participate in an international research study to evaluate the safety and tolerability of an investigational drug for patients with type 2 diabetes and kidney disease. Are you at least 18 years old? Do you have type 2 diabetes mellitus and a clinical diagnosis of kidney disease? Eligible study participants will receive study medications, blood pressure checks, physical exams, laboratory tests and ECG at no cost. Participants will  be reimbursed for time and travel. For more information, call the UAB Hypertension Program at 934-9281 or e-mail ccc-hlnresearch@mail.ad.uab.edu.